Back to search
Tumor-Induced Osteomalacia or Epidermal Nevus Syndrome
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Tumor-Induced Osteomalacia or Epidermal Nevus Syndrome trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Tumor-Induced Osteomalacia or Epidermal Nevus Syndrome trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
The primary objectives of this study are to evaluate the effect of burosumab treatment on: * Increasing serum phosphorus levels in adults with TIO or ENS-assoc…
Before switching to the post-marketing study: To evaluate the efficacy and safety of KRN23 after its 144-week once every 4 weeks (Q4W) repeated SC administrati…